VBLT - Vascular Biogenics Ltd - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Vascular Biogenics Ltd's activity chart (see below) currently has 15 price targets and 14 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.04% with an average time for these price targets to be met of 277.38 days.

Most recent stock forecast was given by MATTHEW BARCUS from CHARDAN CAPITAL on 21-Jul-2022. First documented stock forecast 20-Aug-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Jul-2022

$5

4 years 3 months 22 days ago
(21-Jul-2022)

1/1 (100%)

$-52.05 (-91.24%)

166

Buy Since 15-Oct-2018

$140

4 years 3 months 22 days ago
(20-Jul-2022)

1/4 (25%)

$51.8 (58.73%)

90

Buy Since 27-Jun-2019

$105

$102.24 (3704.35%)

$70

6 years 6 months 25 days ago
(17-Apr-2020)

1/2 (50%)

$57.4 (120.59%)

552

Hold Since 08-Mar-2018

$105

$102.24 (3704.35%)

$875

8 years 8 months 3 days ago
(08-Mar-2018)

1/3 (33.33%)

$12.25 (13.21%)

90

Buy Since 09-Nov-2015

$140

$137.24 (4972.46%)

$455

8 years 8 months 3 days ago
(08-Mar-2018)

0/4 (0%)

$47.25 (50.94%)

Show more analysts

Please expand the browser size to see the chart

What is VBLT (Vascular Biogenics Ltd) average time for price targets to be met?

On average it took 277 days for the stock forecasts to be reached, with an average price target met ratio of 51.04%.

Which analyst most recently updated their price target on VBLT (Vascular Biogenics Ltd)?

Matthew Barcus

Which analyst has the current lower performing score on VBLT (Vascular Biogenics Ltd) with a proven track record?

KEVIN DEGEETER

Which analyst has the most public recommendations on VBLT (Vascular Biogenics Ltd)?

Matthew Barcus works at CHARDAN CAPITAL and has 7 price targets and 5 ratings on VBLT

Which analyst is the currently most bullish on VBLT (Vascular Biogenics Ltd)?

Charles Duncan with the highest potential upside of $137.24

Which analyst is the currently most reserved on VBLT (Vascular Biogenics Ltd)?

Matthew Barcus with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?